Archives

by in
Entry Author Date Location
Aveo Shares Fall as FDA Questions Cancer Drug Survival Trend 08/02/12 Boston
Enlight Bio’s Knode Advances Social Network for Pharma 08/02/12 Boston
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer 07/25/12 San Diego
NanoString Makes IPO Prep Move, Adds Finance Vet to Board 07/18/12 Seattle
WebCollage Takes Ad Copy Mobile for Top Retailers 07/16/12 New York
In Search of Meaningful GAIN in Renewal of Prescription Drug Act 07/11/12 San Diego
Protagonist Criss-Crosses Pacific, in Search of New Peptide Drugs 07/11/12 San Francisco
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
Context Matters Helps Pharma Execs Make Sense of Drug Data 06/20/12 New York
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Metabolic Solutions Announces New Findings in Diabetes Treatment 06/12/12 Detroit
The 2012 New York ASCO Checklist 05/24/12 New York
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study 05/16/12 Boston
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
NIH’s Collins Lauds “Unprecedented” Partnership at NY Bio Confab 05/04/12 New York
Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? 05/03/12 Seattle
Genomic Health, OncoMed Team Up on Personalized Cancer Drug Work 05/02/12 San Francisco
Pfizer Takes on Genzyme With New Gaucher Drug 05/02/12 Boston
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Boston and Cambridge Renew Rivalry in Startup Real Estate 04/13/12 Boston
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup 04/03/12 New York
Transparency Launches as Linux of Drug Development 02/23/12 New York
Satori Snaps Up $15M for Alzheimer’s Drugs 02/23/12 Boston
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects 02/06/12 National
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic 01/31/12 San Diego
Four Themes to Watch in Personalized Medicine 01/30/12 San Francisco
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Page 3 of 16 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.